Track Sai Parenterals Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -5.30 %
Low
540.0
High
594.7
1 Month returns: -2.76 %
Low
540.0
High
706.0
1 Year returns: –
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Sai Parenterals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Sai Parenterals Ltd. Shareholding Pattern
Quarterly breakdown of Sai Parenterals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Sai Parenterals Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Sai Parenterals Ltd.?
The current share price of Sai Parenterals Ltd. is ₹ 556.10 as of 17 Jul 2026.
What is the market capitalisation of Sai Parenterals Ltd.?
The market capitalisation of Sai Parenterals Ltd. stands at ₹ 2,456.79 Cr.
What is the PE ratio of Sai Parenterals Ltd.?
The Price-to-Earnings (PE) ratio of Sai Parenterals Ltd. is 172.30 as of the latest trailing twelve months data.
What is the ROE and ROCE of Sai Parenterals Ltd.?
Sai Parenterals Ltd. has a Return on Equity (ROE) of 4.88% and a Return on Capital Employed (ROCE) of 4.29% as per the latest financial reports.
What is the 52-week high and low of Sai Parenterals Ltd.?
The 52-week high of Sai Parenterals Ltd. is - and the 52-week low is -.
What is the dividend yield of Sai Parenterals Ltd.?
The dividend yield of Sai Parenterals Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Sai Parenterals Ltd.?
Foreign Institutional Investors (FII) hold 5.73%, Domestic Institutional Investors (DII) hold 6.70% and retail/public investors hold 25.49% of Sai Parenterals Ltd. shares.
What sector does Sai Parenterals Ltd. belong to?
Sai Parenterals Ltd. operates in the Healthcare sector.
What is the beta of Sai Parenterals Ltd.?
The beta of Sai Parenterals Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of Sai Parenterals Ltd.?
The 14-day Relative Strength Index (RSI) of Sai Parenterals Ltd. is 42.06, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Mar 2026
Total Promoter
51.16
Indian Promoter
51.16
Foreign Promoter
-
Institutions
18.59
Mutual Funds / UTI
3.81
FI/Bank/Insurance
2.89
Govt
-
FII
5.73
Other Institutions
6.16
Non-Institution
30.26
Bodies Corporate
4.77
Others (incl. Retail)
No. of shareholders
25.49
7,601
Stock Analysis
Fundamental analysis overview of Sai Parenterals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Strong revenue growth and above median growth of industry
The company delivered strong revenue growth of 133.59% for 12-month ended 31 Mar 2026 and the growth was 122.36 percentage points higher than median growth of industry
What is Sales growth (1Y)?
Median: 11.23
Value 133.59
-82.35114662
Strong EPS growth and above median growth of industry
The company delivered strong EPS growth of 33.51% for 12-month ended 31 Mar 2026 and the growth was 25.39 percentage points higher than median growth of industry
What is EPS growth (1Y)?
Low Debt to Equity
The company has low Debt to Equity of 0.68 as on 31 Mar 2026
What is Debt to Equity?
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Expensive and at a premium to industry median P/E
PE TTM of 172.3 indicates that the stock is expensive on a standalone basis and is at a 457.97% premium to industry median P/E
What is P/E Ratio?
Median: 30.88
Value 172.3
-44.893379.36
Weak price momentum
Price Momentum score of 17.4 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term
What is Price Momentum score?
17.4 / 100
Low ROE
The company reported low ROE of 4.88% for 12-month ended 31 Mar 2026
What is ROE (FY)?
Low operating margin
The company reported low operating margin of 5.73% for 12-month ended 31 Mar 2026
What is Operating profit margin?
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Company's earnings are of moderate quality
Earnings quality score of 59.0 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
59.0 / 100
No red flags found!
No significant red flags found in the stock.
No corporate action data available.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
556.10-14.6 (-2.56%)
36.95% since 02 Apr 2026
Company Profile
Overview of Sai Parenterals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Sai Parenterals Ltd is a diversified pharmaceutical formulations company with capabilities in research, development and manufacturing. It is in the business of branded generic formulations and contract development and manufacturing organizational products and services for the domestic and international markets. Its portfolio includes formulation products across various therapeutic areas like cardiovascular, neruopsychiatry, anti-diabetic, respiratory health, antibiotics, vitamins, minerals and supplements analgesics, and dermatology with offerings across dosage forms such as injectables, tablets, capsules, liquid orals and ointments. In the injectables segment, the Company has capabilities in sterile manufacturing for critical care and antibiotics, which are delivered through dry powder injections, pre-filled syringes, ampules, and vials. It manufactures and sells branded generic formulations to a diverse customer base, including central and state government agencies.
Sai Parenterals Ltd is a diversified pharmaceutical formulations company with capabilities in research, development and manufacturing. It is in the business of branded generic formulations and contract development and manufacturing organizational products and services for the domestic and internatio...